MJ Fox Foundation Gives Therapeutic Pipeline Award to Progenra, Supporting Work on New Therapies

MJ Fox Foundation Gives Therapeutic Pipeline Award to Progenra, Supporting Work on New Therapies
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has granted a 2018 Therapeutic Pipeline Award to Progenra to support the company’s development of small molecule treatment candidates for Parkinson’s disease. “Progenra is pleased to have been selected by The Michael J. Fox Foundation to contribute to bringing Parkinson’s and other major neurodegenerative diseases under control by introducing new therapeutic ... read more
Source: Parkinson’s News TodayPublished on 2018-12-21By Jose Marques Lopes, PhD